Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events. results of the St. Francis Heart Study

被引：0
|
作者：
不详
机构：
来源：
KARDIOLOGIYA | 2005年 / 45卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：81 / 81
页数：1
相关论文
共 50 条
  • [41] Commentary: Social class, C-reactive protein and coronary heart disease
    Casas, Juan P.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2008, 37 (02) : 299 - 300
  • [42] Lipoprotein complexed C-reactive protein in patients with coronary heart disease
    Elmas, E
    Kälsch, T
    Borggrefe, M
    Dempfle, CE
    THROMBOSIS AND HAEMOSTASIS, 2005, 94 (05) : 1111 - 1112
  • [43] C-Reactive Protein and Coronary Heart Disease: All Said-Is Not It?
    Strang, Frederik
    Schunkert, Heribert
    MEDIATORS OF INFLAMMATION, 2014, 2014
  • [44] High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease
    Mackness, Bharti
    Hine, David
    McElduff, Patrick
    Mackness, Michael
    ATHEROSCLEROSIS, 2006, 186 (02) : 396 - 401
  • [45] Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus
    Mojiminiyi, OA
    Abdella, N
    Moussa, MA
    Akanji, AO
    Al Mohammedi, H
    Zaki, M
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 58 (01) : 37 - 44
  • [46] Lipoprotein(a) associated risk of atherosclerotic cardiovascular disease is independent of C-reactive protein
    Thomas, Peter Engel
    Vedel-Krogh, Signe
    Afzal, Shoaib
    Nordestgaard, Borge
    Kamstrup, Pia
    CIRCULATION, 2024, 150
  • [47] Elevated Serum C-Reactive Protein Levels Predict Cardiovascular Events in the Japanese Coronary Artery Disease (JCAD) Study
    Shimada, Kenei
    Fujita, Masatoshi
    Tanaka, Atsushi
    Yoshida, Ken
    Jisso, Satoshi
    Tanaka, Hidemasa
    Yoshikawa, Junichi
    Kohro, Takahide
    Hayashi, Doubun
    Okada, Yoshihiro
    Yamazaki, Tsutomu
    Nagai, Ryozo
    CIRCULATION JOURNAL, 2009, 73 (01) : 78 - 85
  • [48] The Role of C-Reactive Protein in Atherosclerotic Cardiovascular Disease: An Overview
    Nakou, Eleni S.
    Liberopoulos, Evangelos N.
    Milionis, Haralampos J.
    Elisaf, Moses S.
    CURRENT VASCULAR PHARMACOLOGY, 2008, 6 (04) : 258 - 270
  • [49] C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project
    Arnold, Natalie
    Blaum, Christopher
    Gossling, Alina
    Brunner, Fabian J.
    Bay, Benjamin
    Ferrario, Marco M.
    Brambilla, Paolo
    Cesana, Giancarlo
    Leoni, Valerio
    Palmieri, Luigi
    Donfrancesco, Chiara
    Padro, Teresa
    Andersson, Jonas
    Jousilahti, Pekka
    Ojeda, Francisco
    Zeller, Tanja
    Linneberg, Allan
    Soederberg, Stefan
    Iacoviello, Licia
    Gianfagna, Francesco
    Sans, Susana
    Veronesi, Giovanni
    Thorand, Barbara
    Peters, Annette
    Tunstall-Pedoe, Hugh
    Kee, Frank
    Salomaa, Veikko
    Schnabel, Renate B.
    Kuulasmaa, Kari
    Blankenberg, Stefan
    Koenig, Wolfgang
    Waldeyer, Christoph
    EUROPEAN HEART JOURNAL, 2024, 45 (12) : 1043 - 1054
  • [50] Polygenic risk score in comparison with C-reactive protein for predicting incident coronary heart disease
    Aday, Aaron W.
    Bagheri, Minoo
    Vaitinadin, Nataraja Sarma
    Mosley, Jonathan D.
    Wang, Thomas J.
    ATHEROSCLEROSIS, 2023, 379
12345